Valuation : BioElectronics Corporation

Market Cap 1.24Cr 1.06Cr 99.8L 91.1L 1.72Cr 118.06Cr 1.72Cr 12Cr 4.62Cr 60Cr 4.64Cr 4.54Cr 197.61Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.21Cr 2.08Cr 1.89Cr 3.57Cr 245.57Cr 3.58Cr 25Cr 9.61Cr 123.96Cr 9.65Cr 9.44Cr 411.04Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 day+11.11%
1 month-14.29%
3 months-14.29%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%0.00%+50.00%-33.33% 74.12L
-1.35%-1.13%+27.04%+14.12% 23TCr
+0.18%-1.27%+5.25%-17.37% 15TCr
+1.51%-1.64%-21.37%+23.59% 13TCr
+0.36%-7.01%-55.71%-12.92% 6.79TCr
+0.29%+0.47%+11.06%+18.65% 5.2TCr
+0.66%-1.69%-16.57%-13.62% 5.1TCr
-2.44%-3.25%+23.11%+28.29% 4.34TCr
-1.56%+0.97%+39.32%+47.34% 4.07TCr
-5.31%-1.74%+117.39%+36.28% 3.26TCr
Average +0.32%-1.25%+17.95%+9.10% 8.01TCr
Weighted average by Cap. -0.46%-1.50%+8.21%+9.30%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.53L 7.93Cr 11.56L 79.52L 31.02L 4Cr 31.15L 30.47L 13Cr 16.09L 13.87L 13L 11.87L 22.36L 15Cr 22.43L 1.54Cr 60.19L 7.76Cr 60.43L 59.11L 26Cr
Net income -11.6L -10L -9L -9L -16.11L -11Cr -16.16L -1.11Cr -43.37L -5.6Cr -43.54L -42.59L -19Cr -3L -2L -2L -2L -4L -2.77Cr -4L -27.78L -10.84L -1.4Cr -10.88L -10.64L -4.64Cr
Net Debt 1.31Cr 1.13Cr 1.06Cr 96.38L 1.82Cr 124.89Cr 1.82Cr 13Cr 4.89Cr 63Cr 4.91Cr 4.8Cr 209.05Cr 1.33Cr 1.15Cr 1.08Cr 98.4L 1.85Cr 127.51Cr 1.86Cr 13Cr 4.99Cr 64Cr 5.01Cr 4.9Cr 213.43Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
28/26/28 $0.000300 +11.11% 1,02,24,000
27/26/27 $0.000270 -10.00% 16,72,000
26/26/26 $0.000300 0.00% 1,58,300
25/26/25 $0.000300 0.00% 1,24,84,589
24/26/24 $0.000300 0.00% 17,93,250
  1. Stock Market
  2. Stocks
  3. BIEL Stock